Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proteimax is a Brazilian biotechnology company specializing in the development and production of high-quality recombinant proteins and molecular biology reagents. Based in Cotia, São Paulo, the company provides a wide range of products including DNA polymerases, restriction enzymes, and molecular weight markers for the research and diagnostic markets. In addition to its product catalog, Proteimax offers specialized services in protein expression, purification, and characterization to support academic and industrial R&D. The company leverages advanced bioprocessing technologies to serve the life sciences sector in South America. By producing these critical tools locally, Proteimax helps reduce the reliance of Brazilian laboratories on imported biotechnology products. The firm is recognized for its technical expertise in enzyme engineering and its contributions to the regional scientific infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proteimax Biotechnologia.